Human Amniotic-Derived Mesenchymal Stem Cell Therapy for Calciphylaxis

Clinical trial NCT04592640 · RECRUITING

Trial details

NCT number: NCT04592640
Sponsor: The First Affiliated Hospital with Nanjing Medical University
Status: RECRUITING
Phase: Early Phase 1
Study type: INTERVENTIONAL

Chronic Kidney Diseases Calciphylaxis Calcific Uremic Arteriolopathy Treatment Safety Efficacy

Start date: 2018-09-17
Primary completion: 2027-09-17
Enrollment: 9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.